Introduction
Qmol KT is a prescription medication that contains the active ingredient Ketorolac. It is available under the brand name Qmol KT. This medication is primarily used for the management of moderate to severe pain.
Uses
Qmol KT is commonly prescribed to relieve pain caused by conditions such as postoperative pain, renal colic, and musculoskeletal injuries. It can be used as a short-term treatment option for pain relief.
Dosage and Administration
Qmol KT is administered by a healthcare professional, usually as an intravenous (IV) or intramuscular (IM) injection. The dosage and frequency of administration will depend on the severity of the pain and the individual patient’s needs. Follow the instructions provided by your healthcare provider and not to exceed the recommended dosage.
Mechanism of Action
Ketorolac, the active ingredient in Qmol KT, belongs to a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by inhibiting the production of certain chemicals in the body that cause pain, inflammation, and fever. By reducing the levels of these chemicals, Qmol KT helps to alleviate pain.
Side Effects
Common side effects may include nausea, vomiting, headache, dizziness, and gastrointestinal disturbances. If any of these side effects persist or worsen, inform your healthcare provider.
In rare cases, Qmol KT may cause more serious side effects such as allergic reactions, stomach ulcers, kidney problems, or bleeding disorders. Seek immediate medical attention if you experience symptoms such as difficulty breathing, chest pain, black or bloody stools, or changes in urination.
Drug Interactions
inform your healthcare provider about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements. Certain medications may interact with Qmol KT, potentially increasing the risk of side effects or reducing its effectiveness.
Some common drug interactions include the use of other NSAIDs, anticoagulants (blood thinners), selective serotonin reuptake inhibitors (SSRIs), and certain diuretics. Your healthcare provider will carefully consider these interactions when prescribing Qmol KT.
Precautions
Before using Qmol KT, inform your healthcare provider about any known allergies, medical conditions, or medications you are currently taking. This medication may not be suitable for individuals with a history of asthma, bleeding disorders, gastrointestinal ulcers, or kidney problems.
Avoid using Qmol KT during pregnancy, especially during the third trimester, as it may harm the unborn baby. It is also not recommended for use while breastfeeding.
Storage
Qmol KT should be stored at room temperature, away from moisture and direct sunlight. Keep it out of the reach of children and pets. Do not use the medication if it has expired or if the solution appears discolored or contains particles.
Patient Tips
- Follow the dosage instructions provided by your healthcare provider and do not exceed the recommended dosage.
- Inform your healthcare provider about any other medications you are taking to prevent potential drug interactions.
- If you experience any unusual or severe side effects, contact your healthcare provider immediately.
- Do not use Qmol KT for a longer duration than prescribed without consulting your healthcare provider.
- Store the medication properly and dispose of any unused portions as directed by your healthcare provider.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Acular (Health Professionals SmPC) Available at:
- Ketorolac nasal (Drugs.com) [Accessed 8 Jun. 2024] (online) Available at:
- ketorolac (pf) dropperette (RX) [Accessed 11 Jun. 2024] (online) Available at:
- Ketorolac Nasal Spray (MedlinePlus) [Accessed 19 Jun. 2024] (online) Available at:
- McNicol ED, Rowe E, Cooper TE. Ketorolac for postoperative pain in children. Cochrane Database Syst Rev. 2018 Jul 7;7(7):CD012294. doi: 10.1002/14651858.CD012294.pub2. [Accessed 6 Jun. 2024] Available at:
Reviews
There are no reviews yet.